Generic drugmaker Actavis has agreed to shut down several plants in New Jersey until they meet U.S. quality standards for the testing and manufacturing of pharmaceuticals. In April, Actavis recalled its generic heart drug Digitek because some tablets may have been twice as thick as they were supposed to be, which would have doubled the dose and created a greater risk of side effects.
Actavis to shut down plants until issues fixed
Published January 9, 2009 News 2 CommentsTags: Actavis, Actavis Totowa, Digitek recall, digoxin, FDA, Food and Drug Admistration, Little Falls, N.J.
2 Responses to “Actavis to shut down plants until issues fixed”
- 1 Trackback on January 29, 2009 at 3:11 pm
Can I use the pictures of the recalled pills allowed in an article I am writing?